Sign Up Today and Learn More About Vascular Therapies Stock
Invest in or calculate the value of your shares in Vascular Therapies or other pre-IPO companies through EquityZen's platform.
Vascular Therapies Stock (VAST)
Vascular Therapies is a biopharma company that aims to improve vascular surgery outcomes in patients with kidney and vascular diseases.
About Vascular Therapies Stock
Founded
2001
Headquarters
Cresskill, NJ, US
Industries
Software, Artificial Intelligence, Data and Analytics
Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.
Vascular Therapies Press Mentions
Stay in the know about the latest news on Vascular Therapies
Unitary product for addressing arteriovenous fistula stenosis
patents • Feb 11, 2025
Vascular Therapies Completes Enrollment in the ACCESS 2 S...
pharmiweb • Aug 05, 2024
Device and method for preventing stenosis at an anastomosis site
patents • Apr 14, 2024
Vascular Therapies Initiates Enrollment in ACCESS 2 Clinical Trial
prnewswire • Aug 29, 2022
Vascular Therapies Completes $25 Million Private Financing
prnewswire • Mar 30, 2022
Vascular Therapies Management
Leadership team at Vascular Therapies
Founder, Chief Scientific Officer & Board Member
Sriram Iyer
CEO
John McDermott
Join now and verify your accreditation status to gain access to:
- Vascular Therapies Current Valuation
- Vascular Therapies Stock Price
- Vascular Therapies Management
- Available deals in Vascular Therapies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Vascular Therapies Cap Table and Funding History by Share Class and Liquidity Preferences
- Vascular Therapies Revenue and Financials
- Vascular Therapies Highlights
- Vascular Therapies Business Model
- Vascular Therapies Risk Factors
- Vascular Therapies Research Report from SACRA Research
Trading Vascular Therapies Stock
How to invest in Vascular Therapies stock?
Accredited investors can buy pre-IPO stock in companies like Vascular Therapies through EquityZen funds. These investments are made available by existing Vascular Therapies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vascular Therapies stock?
Shareholders can sell their Vascular Therapies stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
